Spectrum Pharmaceuticals

About:

Spectrum Pharmaceuticals is a biopharmaceutical company developing drugs to treat oncology and hematology.

Website: http://sppirx.com

Twitter/X: sppirx

Top Investors: Perceptive Advisors, Hanmi Pharmaceutical, Par Pharmaceuticals, Federated Kaufmann Fund, SDS Capital Group

Description:

Spectrum Pharmaceuticals is a biopharmaceutical company that focuses on acquiring, developing, and commercializing novel and targeted drug products, with a primary focus on oncology. It has a strong track record for in-licensing and acquiring differentiated drugs, and for clinical development.

Total Funding Amount:

$236M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Henderson, Nevada, United States

Founded Date:

1987-01-01

Contact Email:

compliance(AT)sppirx.com

Founders:

Jack Baldridge

Number of Employees:

101-250

Last Funding Date:

2022-09-23

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai